SAMBA Home Page Join us at the SAMBA 2008 Mid Year Meeting
Professional Info

eNEWSLETTER
(eBoletín
)

PAGE 1
- President's Address
-

New Committees and Task Forces

- Take the SAMBA Survey on Droperidol
- 2005 Annual Meeting Abstracts
- New Resident Section
- Research
- Future Meetings
- Congratulations to Sara J. Childers, M.D.
PAGE 2
- Join the Discussion
- Last Month's Question with Replies
- This Month's Question
PAGE 3
- From the Literature
- Anesthesia and Analgesia
- Anesthesiology
- ACTA Anaesthesiologica Scandinavica
- British Journal of Anaesthesia
- Canadian Journal of Anesthesia
- Pub Med
PAGE 4
- News for patients
- Sponsors
- Avantgo

Other Issues
  2008
- May
- April
- February
- January
   
  2007
- December
- October
- September
- August
- July
- May
- April
- March
- February
- January
   
  2006
- December
- November
- September
- August
- July
- June
- May
- April
- March
- February
- January
   
  2005
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
   
  2004
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
   
2003
- December
- November
- October
- September
- August

Volume 5, Issue 2
S A M B A T A L K S - PAGE 3
Page 2 Page 4

July, 2005


FROM THE LITERATURE: -
TOP


ANESTHESIA AND ANALGESIA - TOP

Spinal Anesthesia with Hyperbaric Levobupivacaine and Ropivacaine for Outpatient Knee Arthroscopy: A Prospective, Randomized, Double-Blind Study
Gianluca Cappelleri, MD, Giorgio Aldegheri, MD, Giorgio Danelli, MD, Chiara Marchetti, MD, Massimiliano Nuzzi, MD, Gabriella Iannandrea, MD, and Andrea Casati, MD
Anesth Analg 2005;101:77-82

To compare unilateral spinal block produced with small doses of hyperbaric ropivacaine with that produced by 2 doses of hyperbaric levobupivacaine, we randomly allocated 91 ASA physical status I–II outpatients undergoing knee arthroscopy to receive unilateral spinal anesthesia with 7.5 mg of hyperbaric ropivacaine 0.5% (group Ropi-7.5, n = 31) or either 7.5 mg (group Levo-7.5, n = 30) or 5 mg (group Levo-5, n = 30) of hyperbaric levobupivacaine 0.5%. Spinal anesthesia was performed at the L3-4 interspace using a 25-gauge Whitacre spinal needle. The lateral decubitus position was maintained for 15 min after injection. Strictly unilateral sensory block was present in 73%, 50%, and 61% of cases in groups Ropi-7.5, Levo-7.5, and Levo-5, respectively, 30 min after injection (P = 0.40), and unilateral motor block was observed in 94%, 93%, and 83% in groups Ropi-7.5, Levo-7.5, and Levo-5, respectively (P = 0.31). One patient of group Ropi-7.5 required general anesthesia to complete surgery, and fentanyl supplementation was required in one patient of group Ropi-7.5 (3%) and one patient of group Levo-5 (3%) (P = 0.42). The median (range) time for spinal block resolution was shorter in group Ropi-7.5 (135 [126–154] min] than in group Levo-7.5 (162 [148–201] min) (P = 0.04); whereas home discharge was shorter in groups Ropi-7.5 (197 [177–218] min) and Levo-5 (197 [187–251] min) as compared with group Levo-7.5 (238 [219–277] min) (P = 0.02 and P = 0.04, respectively). We conclude that 7.5 mg of 0.5% hyperbaric ropivacaine and 5 mg of 0.5% hyperbaric levobupivacaine provide adequate spinal block for outpatient knee arthroscopy, with a faster home discharge as compared with 7.5 mg of 0.5% hyperbaric levobupivacaine.


Perioperative Rofecoxib Plus Local Anesthetic Field Block Diminishes Pain and Recovery Time After Outpatient Inguinal Hernia Repair
Dorothy J. Pavlin, MD, Edward G. Pavlin, MD, Karen D. Horvath, MD, Laurie B. Amundsen, MD, David R. Flum, MD, MPH, and Kristine Roesen, BA
Anesth Analg 2005;101:83-89

In this study, we compared pain scores after inguinal herniorrhaphy in patients treated by preincisional local anesthetic field block (PL), or PL combined with perioperative rofecoxib, with controls who received standard care. Seventy-five patients having herniorrhaphy under general anesthesia were randomly assigned to receive a placebo pill preoperatively, and for 5 days postoperatively (CONT); preoperative bupivacaine field block and perioperative placebo (PL); preoperative field block plus rofecoxib, 50 mg preoperatively and for 5 days postoperatively (PLR). Bupivacaine infiltration in the wound at closure, IV fentanyl and acetaminophen/oxycodone were administered postoperatively to all. Discharge time, pain scores (0–10), analgesic use, and satisfaction scores (1–6) were compared using analysis of variance. PLR patients had lower maximum pain scores (worst pain) in the postanesthesia care unit (3.7 versus 5.3, P = 0.02) and at 24 h (5.3 versus 6.8, P = 0.03), were discharged 38 min sooner (P = 0.01), required 28% less oxycodone 0–24 h after discharge (P = 0.04), and reported higher satisfaction scores compared with CONT. Pain in PL was less than CONT for 30 min. There were no differences among the 3 groups after 24 h postoperatively. We conclude that perioperative rofecoxib with PL reduces in-hospital recovery time, decreases pain scores and opioid use, and improves satisfaction scores in the first 24 h after surgery.


Intravenous Acetaminophen (Paracetamol): Comparable Analgesic Efficacy, but Better Local Safety than Its Prodrug, Propacetamol, for Postoperative Pain After Third Molar Surgery
Philip Lange Moller, MD, Gitte Irene Juhl, MD, Catherine Payen-Champenois, MD, and Lasse Ansgar Skoglund, DDS, DSci
Anesth Analg 2005;101:90-96

We compared an acetaminophen (paracetamol) 1 g (n = 51) formulation for infusion with propacetamol 2 g (n = 51) and placebo (n = 50) in a randomized, controlled, double-blind, parallel group trial in patients with moderate-to-severe pain after third molar surgery. Treatment efficacy was assessed in house for 6 h after starting the 15-min infusion. Significant effects versus placebo (P < 0.01) were obtained with both active treatments on pain relief, pain intensity difference on a 100-mm visual analog scale, and on a categorical scale (except for propacetamol at 6 h). No significant differences were noted between active groups except at 1 h. Six-hour weighted sums of primary assessments showed significantly better efficacy than placebo (P < 0.0001) and no difference between active treatments. Median stopwatch time to onset of pain relief for active treatment was 6–8 min after infusion start. Active treatments showed comparable efficacy with a significantly longer duration of analgesia and better patients’ global evaluation compared with placebo. The incidence of patients reporting local pain at the infusion site was significantly less frequent after IV acetaminophen or placebo (0%) in comparison with propacetamol (49%). In conclusion, acetaminophen 1 g and propacetamol 2 g were superior to placebo regarding analgesic efficacy, with a more frequent incidence of local pain at the infusion site for propacetamol.


The Different Effects of Intravenous Propofol and Midazolam Sedation on Hemodynamic and Heart Rate Variability
Ni Ni Win, MBBS, Haruhisa Fukayama, DDS, PhD, JBDA, IJBDA, Hikaru Kohase, DDS, PhD, JBDA, IJBDA, and Masahiro Umino, DDS, PhD, JBDA, IJBDA
Anesth Analg 2005;101:97-102

Heart rate (HR) and arterial blood pressure (BP) changes have been reported during conscious sedation with propofol and midazolam. One potential mechanism to explain these changes is that propofol and midazolam affect HR and BP via changes in the cardiac autonomic nervous system. Two specific hypotheses were tested by HR variability analysis: 1) propofol induces predominance of parasympathetic activity, leading to decreased HR and BP, and 2) midazolam induces predominance of sympathetic activity, leading to increased HR and decreased BP. Thirty dental patients were included in a prospective, randomized study. HR, BP, low frequency (LF), high frequency (HF), and entropy were monitored during the awake, sedation, and recovery periods and depth of sedation was assessed using the Observer’s Assessment of Alertness/Sedation score. Propofol induced a significant decrease in total power (503 ± 209 ms2/Hz versus 162 ± 92 ms2/Hz) and LF/HF ratio (2.5 ± 1.2 versus 1.0 ± 0.4), despite the absence of any change in HR during the sedation period compared with baseline. Midazolam decreased normalized HF (34 ± 10% versus 10 ± 4%) but did not significantly change LF/HF ratio (2.3 ± 1.1 versus 2.2 ± 1.4) and increased HR in the sedation period. Compared with baseline, propofol was associated with a significant increase in normalized HF in the recovery period (34 ± 11% versus 44 ± 12%) and a significant decrease in HR, whereas midazolam was associated with an increase in LF/HF ratio (2.3 ± 1.1 versus 3.7 ± 1.8) with no change in HR. These results indicated a dominant parasympathetic effect of propofol and a dominant sympathetic effect of midazolam in both periods. These results should be considered during conscious sedation, especially in patients at risk of cardiovascular complications.


ANESTHESIOLOGY - TOP

Prolongation of QTc Interval after Postoperative Nausea and Vomiting Treatment by Droperidol or Ondansetron.
Charbit, Beny M.D. ; Albaladejo, Pierre M.D., Ph.D. ; Funck-Brentano, Christian M.D., Ph.D. ; Legrand, Mathieu M.D.; Samain, Emmanuel M.D., Ph.D. ; Marty, Jean M.D., Ph.D.
Anesthesiology. 102(6):1094-1100, June 2005.

Background: At dosages above 0.1 mg/kg, droperidol inducesa dose-dependent QTc interval prolongation. Although subject to controversy, low-dose droperidol has recently been suspected to induce cardiac arrhythmias. Hence, 5-hydroxytryptamine type 3 antagonists have become the first-line drug for management of postoperative nausea and vomiting. These drugs are also known to prolong the QTc interval at high dosages. This study describes QTc interval changes associated with postoperative nausea and vomiting treatment by droperidol or ondansetron at low doses.
Methods: Eighty-five patients with postoperative nausea and vomiting were included in this prospective, single-blind study. Patients received either 0.75 mg intravenous droperidol (n = 43) or 4 mg intravenous ondansetron (n = 42). Electrocardiographic recordings were obtained before administration of antiemetic drug and then 1, 2, 3, 5, 10, and 15 min after. Electrocardiographic monitoring was maintained for 3 h in eight patients in each group.
Results: The QTc interval was prolonged (> 450 ms in men, > 470 ms in women) in 21% of the patients before antiemetic drug administration. This was significantly correlated with lower body temperature and longer duration of anesthesia. Compared with predrug QTc measurement, both antiemetics were associated with a significant QTc interval prolongation (P < 0.0001). The mean maximal QTc interval prolongation was 17 +/- 9 ms after droperidol occurring at the second minute and 20 +/- 13 ms after ondansetron at the third minute (both P < 0.0001). Compared with predrug measurement, the QTc interval was significantly lower after the 90th minute in both groups.
Conclusions: Droperidol and ondansetron induced similar clinically relevant QTc interval prolongations. When used in treatment of postoperative nausea and vomiting, a situation where prolongation of the QTc interval seems to occur, the safety of 5-hydroxytryptamine type 3 antagonists may not be superior to that of low-dose droperidol.


Effect of Low-dose Droperidol on the QT Interval during and after General Anesthesia: A Placebo-controlled Study.

White, Paul F. Ph.D., M.D.; Song, Dajun M.D., Ph.D. ; Abrao, Joao M.D., Ph.D. ; Klein, Kevin W. M.D. ; Navarette, Bryan M.S. 
Anesthesiology. 102(6):1101-1105, June 2005.

Abstract:
Background: Since the effects of antiemetic doses of droperidol on the QT interval have not been previously studied, the authors designed a randomized, double-blind, placebo-controlled study to evaluate the intraoperative and postoperative effects of small-dose droperidol (0.625 and 1.25 mg intravenous) on the QT interval when used for antiemetic prophylaxis during general anesthesia.
Methods: One hundred twenty outpatients undergoing otolaryngologic procedures with a standardized general anesthetic technique were enrolled in this study. After anesthetic induction and before the surgical incision, 60 patients were given either saline or 0.625 or 1.25 mg intravenous droperidol in a total volume of 2 ml. A standard electrocardiographic lead II was recorded immediately before and every minute after the injection of the study medication during a 10-min observation period. The QTc (QT interval corrected for heart rate) was evaluated from the recorded electrocardiographic strips. In 60 additional patients, a 12-lead electrocardiogram was obtained before and at specific intervals up to 2 h after surgery to assess the effects of droperidol and general anesthesia on the QTc. Any abnormal heartbeats or arrhythmias during the operation or the subsequent 2-h monitoring interval were also noted.
Results: Intravenous droperidol, 0.625 and 1.25 mg, prolonged the QT interval by an average of 15 +/- 40 and 22 +/- 41 ms, respectively, at 3-6 min after administration during general anesthesia, but these changes did not differ significantly from that seen with saline (12 +/- 35 ms) (all values mean +/- SD). There were no statistically significant differences among the three study groups in the number of patients with greater than 10% prolongation in QTc (vs. baseline). Although general anesthesia was associated with a 14- to 16-ms prolongation of the QTc interval in the early postoperative period, there was no evidence of droperidol-induced QTc prolongation after surgery. Finally, there were no ectopic heartbeats observed on any of the electrocardiographic rhythm strips or 12-lead recordings during the perioperative period.
Conclusion: Use of a small dose of droperidol (0.625-1.25 mg intravenous) for antiemetic prophylaxis during general anesthesia was not associated with a statistically significant increase in the QTc interval compared with saline. More importantly, there was no evidence of any droperidol-induced QTc prolongation immediately after surgery.


Intubating Laryngeal Mask Airway in Morbidly Obese and Lean Patients: A Comparative Study.

Combes, Xavier M.D. ; Sauvat, Stephane M.D. ; Leroux, Bertrand M.D. ; Dumerat, Marc M.D.; Sherrer, Emanuel M.D. ; Motamed, Cyrus M.D. ; Brain, Archie M.D. ; D'Honneur, Gilles M.D. 
Anesthesiology. 102(6):1106-1109, June 2005.

Background: The intubating laryngeal mask airway (ILMA) was designed using the characteristics of healthy-weight subjects but was shown to be an effective airway device in morbidly obese patients. The authors compared airway management quality in morbidly obese and lean patients with use of the ILMA.
Methods: Fifty morbidly obese and 50 lean patients (mean body mass indexes, 42 and 27 kg/m2, respectively) were enrolled in this prospective study. After induction of general anesthesia, characteristics of airway management were judged on safety and efficiency parameters, including success rate at ventilation and intubation and airway management quality criteria, such as the number of patients who required adjustment maneuvers, the number of failed tracheal intubation attempts, the total duration of airway management, and an overall difficulty visual analog scale score.
Results: The ILMA was successfully inserted and adequate ventilation through the ILMA was achieved in all 100 patients. The success rates of tracheal intubation through the ILMA were similar in obese and lean patients (96% and 94%, respectively). The numbers of failed blind tracheal access attempts and patients who required airway-adjustment maneuvers were significantly reduced in obese patients as compared with lean patients. Four obese patients experienced transient episodes of oxygen desaturation (oxygen saturation < 90%) before adequate bag ventilation was established with the ILMA.
Conclusion: The authors confirmed that the ILMA was an efficient airway device for airway management of both lean and obese patients. In the conditions of this study, the authors observed that airway management with the ILMA was simpler in obese patients as compared with lean patients.


Development and Validation of a Perioperative Satisfaction Questionnaire.
Auquier, Pascal M.D., Ph.D. ; Pernoud, Nicolas M.D. ; Bruder, Nicolas M.D. ; Simeoni, Marie-Claude M.D., Ph.D. ; Auffray, Jean-Pierre M.D.; Colavolpe, Christian M.D. ; Francois, Georges M.D.; Gouin, Francois M.D. ; Manelli, Jean-Claude M.D. ; Martin, Claude M.D.; Sapin, Christophe M.Sc.; Blache, Jean-Louis M.D.
Anesthesiology. 102(6):1116-1123, June 2005.

Background: Satisfaction is considered a valuable measure of outcome of healthcare processes. Only a few anesthesia-related validated questionnaires are reported. Because their scope is restricted to specific clinical contexts, their use remains limited. The objective of the current study was to develop and validate a self-reported questionnaire, Evaluation du Vecu de l'Anesthesie Generale (EVAN-G), assessing the satisfaction of the perioperative period surrounding general anesthesia.
Methods: Development of the EVAN-G questionnaire comprised a phase of item generation and a phase of psychometric validation. The patient sample was generated to be proportionally matched to the population of patients undergoing general anesthesia in France. The structure of the questionnaire was identified studying interitem, item-dimension, and interdimension correlations and factor analyses. Data were concurrently gathered to assess external validity. The discriminant validity was determined by comparison of scores across well known patient groups. Reliability was assessed by computation of Cronbach [alpha] coefficients and by test-retest.
Results: Eight hundred seventy-four patients were recruited in eight anesthesia departments. The EVAN-G includes 26 items; six specific scores and one global index score are available. Correlations between EVAN-G scores and other concurrent measures supported convergent validity. The EVAN-G correlated poorly with age, American Society of Anesthesiologists physical status, total anesthesia time, and number of previous anesthesias. Significantly higher satisfaction was reported by patients older than 65 yr, belonging to the laryngeal mask group. Reliability and reproducibility were shown.
Conclusion: The EVAN-G adds important information oriented toward patients' perceptions. The authors' approach provides a novel, valid, and reliable tool that may be used in anesthesia practice.


ACTA ANAESTHESIOLOGICA SCANDINAVICA - TOP

Emotional and interpersonal factors are most important for patient satisfaction with anaesthesia
M. Capuzzo , F. Landi, A. Bassani, L. Grassi, C. A. Volta and R. Alvisi.
Acta Anaesthesiologica Scandinavica Volume 49 Issue 6 Page 759 - July 2005

Background: Questionnaires to evaluate patient satisfaction with anaesthesia mainly consider physiological aspects. This study was performed to identify the items of value for patients having anaesthesia (pilot phase) and to validate the questionnaire built on these findings in a new group of inpatients.
Methods: In the pilot phase, 100 surgical patients were interviewed and asked whether each of the 23 items selected by a panel of providers was relevant (score 1) and to rank these from 1 (additional score 6) to 5 (additional score 2). The resulting 10-item final instrument was administered to 219 consecutive inpatients by interview, after recent anaesthesia, asking them how much of each item they received (item received) and the level of satisfaction with the same item, using Numerical Rating Scales (range 0 alt=- align=bottom>10).
Results: In the pilot phase, gender, age, education and surgery did not influence the score enough to change the first 10 rank-ordered items. The 219 patients subsequently studied did not differ from those missing the questionnaire administration. The patients aged less than 55 years showed lower satisfaction scores than those aged 55 years or more (P = 0.019). In all items, except 'feeling anxious/frightened', the item received was significantly associated with the satisfaction reported. 'Kindness/regard of caregivers' together with 'information given by anaesthetist' and 'feeling safe' predicted 47% of the variance in total patient satisfaction.
Conclusions: Inpatients value highly those elements of care that pertain to emotional and interpersonal relationships.


Relationship between arterial and end-tidal carbon dioxide pressures during anesthesia using a laryngeal tube
J. S. Lee, S. B. Nam, C. H. Chang, D. W. Han, Y. W. Lee and C. S. Shin
Acta Anaesthesiologica Scandinavica Volume 49 Issue 6 Page 759 - July 2005

Background: The Laryngeal Tube® (LT), (VBM Medizintechnik, Sulz, Germany) is a relatively new supraglottic device for controlling the airway. Arterial carbon dioxide tension (PaCO2) can be estimated by monitoring the end-tidal tension of carbon dioxide (PETCO2). The relationship between PETCO2 and PaCO2 during controlled ventilation via the LT has not been reported.
Methods: During general anesthesia, 45 patients were mechanically ventilated using an LT. PETCO2 and PaCO2 were measured once PETCO2 had reached a steady state. The LT was then removed and the trachea intubated using an endotracheal tube (ETT), and the identical ventilatory variables were resumed. Following stabilization, PETCO2 was again determined and PaCO2 estimated.
Results: The mean PETCO2 and PaCO2 values were 4.43 ± 0.26 kPa and 4.67 ± 0.32 kPa, respectively, during LT ventilation, and 4.36 ± 0.23 kPa and 4.61 ± 0.26 kPa, respectively, during ETT ventilation. Analysis of differences between the PETCO2 and PaCO2 values using the Bland and Altman method revealed a bias ± precision of 0.24 ± 0.15 kPa for LT and 0.27 ± 0.15 kPa for ETT. The root mean square error was 0.28 for the LT and 0.30 for the ETT.
Conclusion: This study suggests that for healthy adult patients mechanically ventilated via the LT, the PETCO2 value reflects the PaCO2 value as closely as when patients are ETT ventilated, allowing capnometry to be used to evaluate the adequacy of ventilation.


BRITISH JOURNAL OF ANAESTHESIA - TOP

Chronic postoperative pain: the case of inguinal herniorrhaphy
E. Aasvang and H. Kehlet
British Journal of Anaesthesia 2005 95(1):69-76

Extract: That surgical injury can lead to chronic pain is now well established. From these reviews and studies using a systematic collection of data, the estimated incidences of chronic pain after various procedures are: leg amputation about 60%, thoracotomy about 50%, breast surgery about 30%, cholecystectomy 10–20%, and inguinal herniorrhaphy about 10%. Predictive risk factors for chronic postoperative pain are: preoperative pain, repeat surgery, psychological vulnerability, workers compensation, a surgical approach with risk of nerve damage, moderate or severe intensity of acute postoperative pain, radiation therapy, neurotoxic chemotherapy, depression, neuroticism, and anxiety.


Recent advances in the non-pharmacological management of postoperative nausea and vomiting
D. J. Rowbotham
British Journal of Anaesthesia 2005 95(1):77-81

Extract: Acupuncture is available worldwide for the treatment of many conditions and complaints. In recent years, clinical and laboratory investigations have been conducted in an attempt to provide an evidence-base in support of this technique. Although in some cases the quality of the data is poor, systematic reviews have been published describing the use of acupuncture in chronic pain (e.g. back, neck, arthritis, headache, fibromyalgia), weight reduction, addiction, temporomandibular joint disorders, asthma, smoking cessation, emesis, stroke, and tinnitus. The nature, quality, and implications of the data are often fiercely debated. However, it is generally accepted that there is clear evidence that acupuncture can be effective for nausea and vomiting associated with pregnancy, chemotherapy, and the postoperative period.


CANADIAN JOURNAL OF ANESTHESIA - TOP

Ketorolac analgesia for inguinal hernia repair is not improved by peripheral administration
Kenneth J. Kardash, MD, Jacob Garzon, MD, Ana M. Velly, DDS PhD and Michael J. Tessler, MD
Canadian Journal of Anesthesia 52:613-617 (2005)

Purpose: It has been suggested that ketorolac, a non-steroidal anti-inflammatory drug (NSAID) available for parenteral use, may result in prolonged (24 hr) postoperative analgesia through a peripheral mechanism when added to local anesthetic infiltration. Our objective was to assess this effect by controlling for systemic absorption of the drug.
Methods: This randomized, double-blind trial studied 40 men undergoing elective inguinal hernia repair under spinal anesthesia. All patients received 19 mL of lidocaine 1% infiltrated in the operative field before incision. Patients were randomized into two groups of 20. The surgical site group received ketorolac 30 mg added to the lidocaine infiltration. In the control group, ketorolac 30 mg was injected subcutaneously in the contralateral abdominal wall. Numeric rating scores (0–10) of pain at rest and with movement were recorded at the time of discharge from the recovery room and at 24 hr postoperatively. Time to first analgesia, postoperative iv morphine use, total time in the recovery room, and total oral analgesic use in the first 24 hr were also compared.
Results: There were no significant differences between groups with respect to any of the measured variables. In both groups, pain scores were low at rest (1.9 ± 1.4 vs 2.2 ± 1.8, surgical site and systemic groups, respectively) and moderate with movement (5.3 ± 2.2, 5.0 ± 1.8) after anesthetic recovery. Pain scores were similar at 24 hr (1.1 ± 1.3, 1.9 ± 1.6 at rest; 5.7 ± 2.0, 6.2 ± 2.2 with movement).
Conclusion: Adding ketorolac to lidocaine infiltration for hernia repair does not improve or prolong postoperative analgesia compared to systemic administration.

Apnea during induction of anesthesia with sevoflurane is related to its mode of administration
Carlo Pancaro, MD, Simone Giovannoni, MD, Adelchi Toscano, MD and Vito Aldo Peduto, MD
Canadian Journal of Anesthesia 52:591-594 (2005)

Purpose: The incidence and duration of apnea during sevoflurane anesthesia have not been fully characterized. We hypothesized that sevoflurane at slowly increasing concentrations reduces incidence and shortens the duration of apnea compared to administration of a highly concentrated anesthetic mixture.
Methods: 131 women were randomly assigned to receive 35% oxygen in air and sevoflurane at: incremental concentrations of 1%, from 1% to 8% (group 1–8%, n = 42); decremental-incremental concentrations of 2%, from 8% to 4% and then from 4% to 8% (group 8–4–8%, n = 36); or fixed concentrations of 8% for induction of anesthesia (group 8%, n = 53). A blinded investigator observed whether and for how long patients stopped breathing.
Results: All groups reached 2.5 minimum alveolar concentration of end-tidal sevoflurane. Although apnea was observed in all groups, it was more frequent in the 8% group than in 1 to 8% (68% vs 21%, P < 0.05) or 8 to 4 to 8% groups (68% vs 20%, P < 0.05). Duration of apnea was also more pronounced in the 8% group than in 1 to 8% and 8 to 4 to 8% groups ( 58 ± 25 s vs 32 ± 18 sec, P < 0.05 and vs 35 ± 16 sec, P < 0.05, respectively).
Conclusions: Sevoflurane induces apnea more frequently and for longer duration at a fixed high concentration compared to incremental or decremental-incremental concentrations. Decremental-incremental concentrations offer the additional advantage of a speed of induction similar to that elicited by the 8% concentration.


- TOP

Hemodynamics and oxygen saturation during intravenous sedation for office-based laser-assisted uvuloplasty
Cillo JE, Finn R.

J Oral Maxillofac Surg. 2005 Jun;63(6):752-5

PURPOSE: Patients undergoing office-based laser-assisted uvuloplasty (LAUP) for snoring or mild obstructive sleep apnea are generally obese and have a high Mallampati score. Because avoidance of supplemental oxygen during laser procedures is generally mandated, the potential for intraoperative desaturation is high. This study was designed to look at intraoperative hemodynamic changes, respiration patterns, and oxygen saturations during intravenous sedation with midazolam and fentanyl during LAUP procedures.
MATERIALS AND METHODS: This was a retrospective anesthesia chart review of 15 consecutive patients undergoing midazolam/fentanyl intravenous sedation for office-based LAUP treatment for snoring and/or mild obstructive sleep apnea. Data recorded were noninvasive baseline and intraoperative hemodynamic measurements at 5-minute intervals for systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), pulse pressure (PP), pulse (P), and rate-pressure product (RPP). Data collected were reported as mean values with standard deviation. Statistical analysis using the Student's t test was performed and found significant for P<.05.
RESULTS: All changes from baseline were statistically insignificant, SBP (P=.4), DBP (P=.2), MAP (P=.2), P (P=.1), PP (P=.9), RPP (P=.5), RR (P=.9), and SpO2 (P=.4), and all within +/-20% of baseline (range, -5.0% to +7.5%).
CONCLUSION: Midazolam and fentanyl intravenous sedation with local anesthesia maintained intraoperative hemodynamic and oxygenation variables close to baseline for office-based LAUP procedures.

TOP

PAGE 2    PAGE 4


© SOCIETY FOR AMBULATORY ANESTHESIA
520 N. Northwest Highway Park Ridge, Illinois 60068-2573
Tel: (847) 825-5586 Fax: (847) 825-5658
E-mail: samba@asahq.org